- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03154502
Sodium Intake in Ecuadorian Population
May 12, 2017 updated by: Ivan Sisa, Universidad San Francisco de Quito
Sodium Urinary Excretion Measurement in Ecuadorian Population
This study is aim to determine the sodium intake in Ecuadorian population that is an unknown information at present.
For that, 24h urine samples will be collected from 130 subjects working either at tue USFQ or HDLV to measure sodium excretion.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
130
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Will be enrolled a sample of 178 adults aged 25 to 64 years.
The research team, who have faculty appointments in USFQ, supervised the collection of the urine samples.
We invited a broad spectrum of employees (which included health care workers, professors, and custodial staff) from both institutions to participate in the study.
Description
Inclusion Criteria:
- None
Exclusion Criteria:
- unable to provide informed consent
- unable to provide 24-hr urine excretion sample
- those with a known history of heart or kidney failure, stroke, and liver disease
- those using diuretics, multivitamins, NSADs, or prostaglandins during the last two weeks
- pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urinary sodium excretion
Time Frame: 1 year
|
Amount of sodium in 24h urine collection
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Enrique Teran, MD, PhD, Universidad San Francisco de Quito
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2015
Primary Completion (Actual)
October 30, 2016
Study Completion (Actual)
October 30, 2016
Study Registration Dates
First Submitted
May 12, 2017
First Submitted That Met QC Criteria
May 12, 2017
First Posted (Actual)
May 16, 2017
Study Record Updates
Last Update Posted (Actual)
May 16, 2017
Last Update Submitted That Met QC Criteria
May 12, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUBI-1022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk Factor, Cardiovascular
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
University of Split, School of MedicineCompletedCardiovascular Risk Factor | Lifestyle Risk ReductionCroatia
-
University of DelawareRecruiting
-
University Health Network, TorontoSunnybrook Health Sciences Centre; MOUNT SINAI HOSPITALRecruitingCardiovascular Risk FactorCanada
-
University of DelawareRecruitingCardiovascular Risk FactorUnited States
-
The Cleveland ClinicActive, not recruitingCardiovascular Risk FactorUnited States
-
University of NebraskaCompletedCardiovascular Risk FactorUnited States
-
Oregon Health and Science UniversityCompleted
-
Dawn BrewerNational Institute of Environmental Health Sciences (NIEHS)Completed
-
Penn State UniversityActive, not recruitingCardiovascular Risk FactorUnited States
Clinical Trials on Urinary sodium excretion
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University Hospital, GhentCompletedCystic Fibrosis | Salt; Deficit (or Low)Belgium
-
Dr Alexandre GrosCompleted
-
University of Campania "Luigi Vanvitelli"CompletedDiabetes Mellitus, Type 1 | Food HabitsItaly
-
Rennes University HospitalCompleted
-
Radboud University Medical CenterCompletedInsulin ResistanceNetherlands
-
Queen Mary University of LondonLAPresearch UKUnknown
-
Cairo UniversityUnknown
-
University of BrawijayaRecruitingEnterocolitis, Necrotizing | Infant, PrematureIndonesia